# Samer K. Khaled, M.D. – FDA Inspection, Jan 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/samer-k-khaled-md/aaba5d74-3f67-402f-acaa-726e1cc17f32
Source feed: FDA_Inspections

> FDA inspection 1077396 of Samer K. Khaled, M.D., January 18, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1077396
- Company Name: Samer K. Khaled, M.D.
- Inspection Date: 2019-01-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1134243 - 2020-12-23](https://www.keypedia.com/records/fda_inspections/samer-k-khaled-md/3fd02b90-972c-4a31-b547-f32412363d4e)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/diane-c-van-leeuwen/98af0d70-2db1-4132-8193-fcccf8841960)

Company: https://www.keypedia.com/companies/samer-k-khaled-md/daa94244-9556-4238-a190-7d599a3b496a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
